Davis's Drug Guide
belzutifan
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
bel-zue-ti-fan
Trade Name(s)
- Welireg
Ther. Class.
Pharm. Class.
temporary class
hypoxia-inducible factor 2 alpha inhibitorThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Belzutifan." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110962/5/belzutifan.
Vallerand AHA, Sanoski CAC. Belzutifan. Davis's Drug Guide. F.A. Davis Company; 2026. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110962/5/belzutifan. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Belzutifan. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110962/5/belzutifan
Vallerand AHA, Sanoski CAC. Belzutifan [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110962/5/belzutifan.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - belzutifan
ID - 110962
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110962/5/belzutifan
PB - F.A. Davis Company
ET - 20
DB - Emergency Central
DP - Unbound Medicine
ER -
